Vancomycin-resistant Enterococcus colonization in the intensive care unit: Clinical outcomes and attributable costs of hospitalization
The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients c...
Saved in:
Published in | American journal of infection control Vol. 42; no. 10; pp. 1062 - 1066 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.10.2014
Elsevier Mosby-Year Book, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0196-6553 1527-3296 1527-3296 |
DOI | 10.1016/j.ajic.2014.06.024 |
Cover
Loading…
Abstract | The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.
We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.
During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).
Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. |
---|---|
AbstractList | The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.
We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.
During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).
Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. Background The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. Methods We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. Results During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Conclusion Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.BACKGROUNDThe clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.METHODSWe performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).RESULTSDuring the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.CONCLUSIONCompared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful. |
Author | Byun, Sookjin Lee, Hojin Lee, Hyuck Moon, Sang Yi Jung, Euihan |
Author_xml | – sequence: 1 givenname: Euihan orcidid: 0000-0002-8515-4927 surname: Jung fullname: Jung, Euihan organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea – sequence: 2 givenname: Sookjin surname: Byun fullname: Byun, Sookjin organization: Infection Control Office, Dong-A University Hospital, Busan, Korea – sequence: 3 givenname: Hojin surname: Lee fullname: Lee, Hojin organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea – sequence: 4 givenname: Sang Yi surname: Moon fullname: Moon, Sang Yi organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea – sequence: 5 givenname: Hyuck orcidid: 0000-0002-4115-0748 surname: Lee fullname: Lee, Hyuck email: hleeid@dau.ac.kr organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28886891$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/25278394$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktr3DAUhUVJaSZp_0AXRVAK2Xiqh6WxQymUIX1AoIs-tkKWrolcjzSV5MD0B_R3R2YmBAaari6I7xxdzrln6MQHDwi9pGRJCZVvh6UenFkyQuslkUvC6idoQQVbVZy18gQtCG1lJYXgp-gspYEQ0nIpnqFTVqCGt_UC_f2pvQmbnXG-ipBcytpnfOUzxGCCMVPCJozBuz86u-Cx8zjfQBkZfHK3gI2OgCfv8iVej847o0ccplw8IWHtLdY5R9dNWXdjoUPKCYce34S0dVmPB9_n6GmvxwQvDvMc_fh49X39ubr--unL-sN1ZQQjueIN6c1KaCs6axvKy2NrNeWsszWXK65ltxJWStt1fddw3dadrAlQJmrbakb5ObrY-25j-D1BymrjkoFx1B7ClBQVjaREFLKgr4_QIUzRl-0UlZRKQUXdFurVgZq6DVi1jW6j407dJ1yANwdAp5JNH0veLj1wTdPIpp03a_aciSGlCL0yJZ85mxy1GxUlai5dDWouXc2lKyJVKb1I2ZH03v1R0bu9CErctw6iSsaBN2BdBJOVDe5x-fsjuTm0_wt2kB6iUokpor7NpzhfIq3nI2xJMbj8t8H_fr8DjKPvYQ |
CitedBy_id | crossref_primary_10_1186_s13099_018_0259_4 crossref_primary_10_1186_s13613_021_00976_5 crossref_primary_10_1016_j_jgar_2019_06_022 crossref_primary_10_1016_j_surg_2025_109152 crossref_primary_10_1017_ice_2017_248 crossref_primary_10_1080_19490976_2024_2351478 crossref_primary_10_1007_s00103_018_2811_2 crossref_primary_10_1016_j_jhin_2018_02_016 crossref_primary_10_1016_j_diagmicrobio_2017_08_009 crossref_primary_10_1016_j_infpip_2024_100413 crossref_primary_10_1017_ash_2021_215 crossref_primary_10_3389_fimmu_2017_01890 crossref_primary_10_1186_s12879_021_06386_z crossref_primary_10_1186_s13756_022_01081_3 crossref_primary_10_1111_tid_13821 crossref_primary_10_1186_s13756_017_0291_z crossref_primary_10_1016_j_jhin_2018_07_018 crossref_primary_10_1177_1073274818794162 crossref_primary_10_1007_s00134_018_5268_8 crossref_primary_10_1186_s12879_023_08238_4 crossref_primary_10_1093_ofid_ofw133 crossref_primary_10_1097_BOT_0000000000000750 crossref_primary_10_3390_nu11123002 crossref_primary_10_3947_ic_2016_48_3_174 crossref_primary_10_1093_ejcts_ezv453 crossref_primary_10_1111_cbdd_13569 crossref_primary_10_1016_j_nmni_2021_100881 crossref_primary_10_1016_j_molmed_2019_04_011 crossref_primary_10_1186_2197_425X_3_S1_A124 crossref_primary_10_1016_j_amjms_2018_08_015 crossref_primary_10_1016_j_ajic_2015_11_026 crossref_primary_10_2807_1560_7917_ES_2022_27_5_2001660 crossref_primary_10_1186_s13756_019_0590_7 crossref_primary_10_1186_s13054_019_2488_4 crossref_primary_10_1186_s12913_018_3549_0 crossref_primary_10_1007_s10096_015_2436_4 crossref_primary_10_5392_JKCA_2015_15_06_346 |
Cites_doi | 10.1001/archinte.165.3.302 10.1056/NEJM200003093421007 10.7883/yoken.65.57 10.2307/30141777 10.1016/S0140-6736(88)91037-9 10.1056/NEJMoa1000373 10.1016/j.ajic.2006.04.205 10.1001/archinte.162.19.2223 10.1001/archinte.158.10.1127 10.1016/j.ajic.2012.01.009 10.1016/j.ijantimicag.2003.12.019 10.1016/j.ajic.2012.04.331 10.1164/ajrccm.160.3.9808145 10.1016/j.ajic.2008.09.025 10.4040/jkan.2013.43.2.287 10.1016/j.ijid.2012.09.019 10.1086/502213 10.1086/512261 10.2307/2532206 10.1086/524331 |
ContentType | Journal Article |
Copyright | 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Association for Professionals in Infection Control and Epidemiology, Inc. 2015 INIST-CNRS Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. Copyright Mosby-Year Book, Inc. Oct 2014 |
Copyright_xml | – notice: 2014 Association for Professionals in Infection Control and Epidemiology, Inc. – notice: Association for Professionals in Infection Control and Epidemiology, Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. – notice: Copyright Mosby-Year Book, Inc. Oct 2014 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ajic.2014.06.024 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1527-3296 |
EndPage | 1066 |
ExternalDocumentID | 3460960141 25278394 28886891 10_1016_j_ajic_2014_06_024 S0196655314009390 1_s2_0_S0196655314009390 |
Genre | Journal Article Observational Study Feature |
GroupedDBID | --- --K --M ..I .1- .FO .GJ .~1 0-6 0R~ 1B1 1P~ 1RT 1Z5 1~. 1~5 23M 2KS 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AAAJQ AABNK AABSN AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACJTP ACRLP ACRPL ACVFH ACXZT ADBBV ADCNI ADEZE ADIMB ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXBA AFXIZ AGBRE AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BEEDS BKOJK BLXMC BNPGV C45 CAG CJTIS COF COPKO CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FAFAN FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEJ HMK HMO HVGLF HZ~ H~W IH2 IHE J1W J5H K-O KOM L7B LUGTX M27 M41 MO0 N4W N9A O-L O9- OAUVE OD- OEN OMK ONC ONOOK OO. OUGNH OVD OZT P-8 P-9 PC. PQQKQ Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SNC SND SNG SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UHS UV1 WH7 WOQ WOW WUQ XCE YFH YOC Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AISVY AJBFU EFLBG LCYCR NAHTW ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c520t-380fc75ad5bdd8135209da132bd43673a6b75d66dbbfb83a94b640e1254d9a213 |
IEDL.DBID | .~1 |
ISSN | 0196-6553 1527-3296 |
IngestDate | Thu Jul 10 22:10:25 EDT 2025 Sun Jul 13 04:23:07 EDT 2025 Mon Jul 21 06:01:28 EDT 2025 Wed Apr 02 07:16:15 EDT 2025 Tue Jul 01 01:59:36 EDT 2025 Thu Apr 24 22:53:09 EDT 2025 Fri Feb 23 02:32:48 EST 2024 Sun Feb 23 10:19:18 EST 2025 Tue Aug 26 16:32:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Enterococcus Intensive care units Vancomycin resistance Infection control Costs Prognosis Check Hospitalization Intensive care unit Prevention Infection Streptococcaceae Health economy Bacteria Micrococcales Public health Colonization |
Language | English |
License | CC BY 4.0 Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c520t-380fc75ad5bdd8135209da132bd43673a6b75d66dbbfb83a94b640e1254d9a213 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-8515-4927 0000-0002-4115-0748 |
PMID | 25278394 |
PQID | 1611651549 |
PQPubID | 105487 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1586105213 proquest_journals_1611651549 pubmed_primary_25278394 pascalfrancis_primary_28886891 crossref_citationtrail_10_1016_j_ajic_2014_06_024 crossref_primary_10_1016_j_ajic_2014_06_024 elsevier_sciencedirect_doi_10_1016_j_ajic_2014_06_024 elsevier_clinicalkeyesjournals_1_s2_0_S0196655314009390 elsevier_clinicalkey_doi_10_1016_j_ajic_2014_06_024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-10-01 |
PublicationDateYYYYMMDD | 2014-10-01 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
PublicationTitle | American journal of infection control |
PublicationTitleAlternate | Am J Infect Control |
PublicationYear | 2014 |
Publisher | Elsevier Inc Elsevier Mosby-Year Book, Inc |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Mosby-Year Book, Inc |
References | Parsons (bib8) 2000 Greenland, Drescher (bib9) 1993; 49 Huskins, Huckabee, O'Grady, Murray, Kopetskie, Zimmer (bib22) 2011; 364 Muto, Jernigan, Ostrowsky, Richet, Jarvis, Boyce (bib19) 2003; 24 Carmeli, Eliopoulos, Mozaffari, Samore (bib15) 2002; 162 Kim, Kim, Kim, Lee, Park, Kang (bib13) 2012; 40 Duckro, Blom, Lyle, Weinstein, Hayden (bib21) 2005; 165 Park, Jeong, Park, Shin, Kim, Lee (bib23) 2007; 12 Song, Cheong, Jo, Choi, Noh, Heo (bib14) 2009; 37 Kee, Park, Lee, Kwon, Pyo, Western Dialysis Physical Association (bib12) 2012; 65 Bonten, Slaughter, Ambergen, Hayden, van Voorhis, Nathan (bib6) 1998; 158 Efe Iris, Sayıner, Yildirmak, Simsek, Arat (bib11) 2013; 41 Weber, Huang, Oriola, Huskins, Noskin, Harriman (bib20) 2007; 28 Martone (bib2) 1998; 19 Matar, Tarrand, Raad, Rolston (bib10) 2006; 34 Digiovine, Chenoweth, Watts, Higgins (bib16) 1999; 160 Streit, Jones, Sader, Fritsche (bib3) 2004; 24 Hayden, Blom, Lyle, Moore, Weinstein (bib18) 2008; 29 Uttley, Collins, Naidoo, George (bib1) 1988; 1 Byun, Kang (bib7) 2013; 43 Murray (bib5) 2000; 342 Sohn, Peck, Joo, Ha, Kang, Chung (bib17) 2013; 17 Cheong, Song, Eom, Kim, Choi, Choi (bib4) 2002; 34 Matar (10.1016/j.ajic.2014.06.024_bib10) 2006; 34 Song (10.1016/j.ajic.2014.06.024_bib14) 2009; 37 Parsons (10.1016/j.ajic.2014.06.024_bib8) 2000 Weber (10.1016/j.ajic.2014.06.024_bib20) 2007; 28 Streit (10.1016/j.ajic.2014.06.024_bib3) 2004; 24 Park (10.1016/j.ajic.2014.06.024_bib23) 2007; 12 Sohn (10.1016/j.ajic.2014.06.024_bib17) 2013; 17 Byun (10.1016/j.ajic.2014.06.024_bib7) 2013; 43 Efe Iris (10.1016/j.ajic.2014.06.024_bib11) 2013; 41 Kim (10.1016/j.ajic.2014.06.024_bib13) 2012; 40 Cheong (10.1016/j.ajic.2014.06.024_bib4) 2002; 34 Murray (10.1016/j.ajic.2014.06.024_bib5) 2000; 342 Digiovine (10.1016/j.ajic.2014.06.024_bib16) 1999; 160 Duckro (10.1016/j.ajic.2014.06.024_bib21) 2005; 165 Martone (10.1016/j.ajic.2014.06.024_bib2) 1998; 19 Kee (10.1016/j.ajic.2014.06.024_bib12) 2012; 65 Uttley (10.1016/j.ajic.2014.06.024_bib1) 1988; 1 Greenland (10.1016/j.ajic.2014.06.024_bib9) 1993; 49 Muto (10.1016/j.ajic.2014.06.024_bib19) 2003; 24 Huskins (10.1016/j.ajic.2014.06.024_bib22) 2011; 364 Bonten (10.1016/j.ajic.2014.06.024_bib6) 1998; 158 Carmeli (10.1016/j.ajic.2014.06.024_bib15) 2002; 162 Hayden (10.1016/j.ajic.2014.06.024_bib18) 2008; 29 |
References_xml | – volume: 165 start-page: 302 year: 2005 end-page: 307 ident: bib21 article-title: Transfer of vancomycin-resistant enterococci via health care worker hands publication-title: Arch Intern Med – volume: 19 start-page: 539 year: 1998 end-page: 545 ident: bib2 article-title: Spread of vancomycin-resistant enterococci: why did it happen in the United States? publication-title: Infect Control Hosp Epidemiol – volume: 1 start-page: 57 year: 1988 end-page: 58 ident: bib1 article-title: Vancomycin-resistant enterococci publication-title: Lancet – volume: 24 start-page: 111 year: 2004 end-page: 118 ident: bib3 article-title: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001) publication-title: Int J Antimicrob Agents – volume: 43 start-page: 287 year: 2013 end-page: 295 ident: bib7 article-title: Risk factors and clinical outcomes for vancomycin-resistant Enterococcus colonization on intensive care unit admission [Korean] publication-title: J Korean Acad Nurs – start-page: 214 year: 2000 end-page: 226 ident: bib8 article-title: Using SAS® software to perform a case control match on propensity score in an observational study – volume: 162 start-page: 2223 year: 2002 end-page: 2228 ident: bib15 article-title: Health and economic outcomes of vancomycin-resistant enterococci publication-title: Arch Intern Med – volume: 160 start-page: 976 year: 1999 end-page: 981 ident: bib16 article-title: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit publication-title: Am J Respir Crit Care Med – volume: 17 start-page: e240 year: 2013 end-page: e246 ident: bib17 article-title: Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital publication-title: Int J Infect Dis – volume: 37 start-page: 734 year: 2009 end-page: 740 ident: bib14 article-title: Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis publication-title: Am J Infect Control – volume: 65 start-page: 57 year: 2012 end-page: 60 ident: bib12 article-title: Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis publication-title: Jpn J Infect Dis – volume: 29 start-page: 149 year: 2008 end-page: 154 ident: bib18 article-title: Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment publication-title: Infect Control Hosp Epidemiol – volume: 34 start-page: 276 year: 2002 end-page: 284 ident: bib4 article-title: Colonization rate, risk factor for acquisition, and genetic diversity of vancomycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea publication-title: Korean J Infect Dis – volume: 41 start-page: 261 year: 2013 end-page: 262 ident: bib11 article-title: Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors publication-title: Am J Infect Control – volume: 342 start-page: 710 year: 2000 end-page: 721 ident: bib5 article-title: Vancomycin-resistant enterococcal infections publication-title: New Engl J Med – volume: 34 start-page: 534 year: 2006 end-page: 536 ident: bib10 article-title: Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer publication-title: Am J Infect Control – volume: 49 start-page: 865 year: 1993 end-page: 872 ident: bib9 article-title: Maximum likelihood estimation of the attributable fraction from logistic models publication-title: Biometrics – volume: 24 start-page: 362 year: 2003 end-page: 386 ident: bib19 article-title: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus publication-title: Infect Control Hosp Epidemiol – volume: 158 start-page: 1127 year: 1998 end-page: 1132 ident: bib6 article-title: The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable publication-title: Arch Intern Med – volume: 40 start-page: 1018 year: 2012 end-page: 1019 ident: bib13 article-title: Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission publication-title: Am J Infect Control – volume: 28 start-page: 249 year: 2007 end-page: 260 ident: bib20 article-title: Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force publication-title: Infect Control Hosp Epidemiol – volume: 12 start-page: 112 year: 2007 end-page: 121 ident: bib23 article-title: Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea publication-title: Korean J Nosocomial Infect Control – volume: 364 start-page: 1407 year: 2011 end-page: 1418 ident: bib22 article-title: Intervention to reduce transmission of resistant bacteria in intensive care publication-title: N Engl J Med – volume: 165 start-page: 302 year: 2005 ident: 10.1016/j.ajic.2014.06.024_bib21 article-title: Transfer of vancomycin-resistant enterococci via health care worker hands publication-title: Arch Intern Med doi: 10.1001/archinte.165.3.302 – volume: 34 start-page: 276 year: 2002 ident: 10.1016/j.ajic.2014.06.024_bib4 article-title: Colonization rate, risk factor for acquisition, and genetic diversity of vancomycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea publication-title: Korean J Infect Dis – volume: 342 start-page: 710 year: 2000 ident: 10.1016/j.ajic.2014.06.024_bib5 article-title: Vancomycin-resistant enterococcal infections publication-title: New Engl J Med doi: 10.1056/NEJM200003093421007 – volume: 65 start-page: 57 year: 2012 ident: 10.1016/j.ajic.2014.06.024_bib12 article-title: Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis publication-title: Jpn J Infect Dis doi: 10.7883/yoken.65.57 – volume: 19 start-page: 539 year: 1998 ident: 10.1016/j.ajic.2014.06.024_bib2 article-title: Spread of vancomycin-resistant enterococci: why did it happen in the United States? publication-title: Infect Control Hosp Epidemiol doi: 10.2307/30141777 – volume: 1 start-page: 57 year: 1988 ident: 10.1016/j.ajic.2014.06.024_bib1 article-title: Vancomycin-resistant enterococci publication-title: Lancet doi: 10.1016/S0140-6736(88)91037-9 – start-page: 214 year: 2000 ident: 10.1016/j.ajic.2014.06.024_bib8 – volume: 364 start-page: 1407 year: 2011 ident: 10.1016/j.ajic.2014.06.024_bib22 article-title: Intervention to reduce transmission of resistant bacteria in intensive care publication-title: N Engl J Med doi: 10.1056/NEJMoa1000373 – volume: 12 start-page: 112 year: 2007 ident: 10.1016/j.ajic.2014.06.024_bib23 article-title: Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea publication-title: Korean J Nosocomial Infect Control – volume: 34 start-page: 534 year: 2006 ident: 10.1016/j.ajic.2014.06.024_bib10 article-title: Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer publication-title: Am J Infect Control doi: 10.1016/j.ajic.2006.04.205 – volume: 162 start-page: 2223 year: 2002 ident: 10.1016/j.ajic.2014.06.024_bib15 article-title: Health and economic outcomes of vancomycin-resistant enterococci publication-title: Arch Intern Med doi: 10.1001/archinte.162.19.2223 – volume: 158 start-page: 1127 year: 1998 ident: 10.1016/j.ajic.2014.06.024_bib6 article-title: The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable publication-title: Arch Intern Med doi: 10.1001/archinte.158.10.1127 – volume: 40 start-page: 1018 year: 2012 ident: 10.1016/j.ajic.2014.06.024_bib13 article-title: Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission publication-title: Am J Infect Control doi: 10.1016/j.ajic.2012.01.009 – volume: 24 start-page: 111 year: 2004 ident: 10.1016/j.ajic.2014.06.024_bib3 article-title: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001) publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2003.12.019 – volume: 41 start-page: 261 year: 2013 ident: 10.1016/j.ajic.2014.06.024_bib11 article-title: Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors publication-title: Am J Infect Control doi: 10.1016/j.ajic.2012.04.331 – volume: 160 start-page: 976 year: 1999 ident: 10.1016/j.ajic.2014.06.024_bib16 article-title: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.160.3.9808145 – volume: 37 start-page: 734 year: 2009 ident: 10.1016/j.ajic.2014.06.024_bib14 article-title: Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis publication-title: Am J Infect Control doi: 10.1016/j.ajic.2008.09.025 – volume: 43 start-page: 287 year: 2013 ident: 10.1016/j.ajic.2014.06.024_bib7 article-title: Risk factors and clinical outcomes for vancomycin-resistant Enterococcus colonization on intensive care unit admission [Korean] publication-title: J Korean Acad Nurs doi: 10.4040/jkan.2013.43.2.287 – volume: 17 start-page: e240 year: 2013 ident: 10.1016/j.ajic.2014.06.024_bib17 article-title: Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2012.09.019 – volume: 24 start-page: 362 year: 2003 ident: 10.1016/j.ajic.2014.06.024_bib19 article-title: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus publication-title: Infect Control Hosp Epidemiol doi: 10.1086/502213 – volume: 28 start-page: 249 year: 2007 ident: 10.1016/j.ajic.2014.06.024_bib20 article-title: Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force publication-title: Infect Control Hosp Epidemiol doi: 10.1086/512261 – volume: 49 start-page: 865 year: 1993 ident: 10.1016/j.ajic.2014.06.024_bib9 article-title: Maximum likelihood estimation of the attributable fraction from logistic models publication-title: Biometrics doi: 10.2307/2532206 – volume: 29 start-page: 149 year: 2008 ident: 10.1016/j.ajic.2014.06.024_bib18 article-title: Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment publication-title: Infect Control Hosp Epidemiol doi: 10.1086/524331 |
SSID | ssj0009365 |
Score | 2.2780836 |
Snippet | The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting... Background The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1062 |
SubjectTerms | Biological and medical sciences Clinical outcomes Cohort Studies Comparative analysis Economic impact Enterococcus Enterococcus - drug effects Enterococcus - isolation & purification Epidemiology. Vaccinations Female General aspects Gram-Positive Bacterial Infections - economics Gram-Positive Bacterial Infections - epidemiology Gram-Positive Bacterial Infections - mortality Health Care Costs Hospitalization Humans Infection Control Infectious Disease Infectious diseases Intensive care Intensive Care Units Length of Stay Male Medical sciences Middle Aged Mortality Nosocomial infections Retrospective Studies Survival Analysis Treatment Outcome Vancomycin Resistance |
Title | Vancomycin-resistant Enterococcus colonization in the intensive care unit: Clinical outcomes and attributable costs of hospitalization |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0196655314009390 https://www.clinicalkey.es/playcontent/1-s2.0-S0196655314009390 https://dx.doi.org/10.1016/j.ajic.2014.06.024 https://www.ncbi.nlm.nih.gov/pubmed/25278394 https://www.proquest.com/docview/1611651549 https://www.proquest.com/docview/1586105213 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckGqEG8CZWUkbijsOn4k4VZVVAtIvUBRb5YfiUjVJiuSHLhw5HczEzu7qqBF4rhZe-K1Z8bj9TffEPLaM8fryhRp5cDIRaFYapzFW_acZcrxQrkJbXGq1mfi47k83yPHcy4Mwiqj7w8-ffLW8ckyzuZy0zTLz8jsoiTokMBjeYnndmSvA51--3MH8yi5CjDGUqXYOibOBIyXuWiQxpCJicMzEzdtTgcb08OU1aHWxc3B6LQpndwn92I0SY_CgB-Qvap9SA7CX3E0ZBg9Ir--grzu6odr2hQO1xgwtgOd0AAduEM39hSpq-eMTNq0FKJC2szgdoroMDqC7b-jkUb0knbjADKrnprWUzOEulmYhgWy-qGnXU2_xZIkUe5jcnby_svxOo3lF1Ins9WQ8mJVu1waL633BeMImPEGTq_WC65ybpTNpVfKW1vbgptSWCVWFURMwpcmY_wJ2W-7tnpGqBeslJmVzOTQRJZWmdzjBaHyGXfeJ4TN865d5CbHEhmXegahXWhcK41rpRGJl4mEvNn22QRmjltb83k59ZxzCl5Sw8Zxa6_8b72qPhp6r5nuM73SfyhjQuS25zV9_ucbF9d0bfvTsqIoVFGyhBzOyqd3o1DIooRsewl5tf0aHAXe_pi26kZoI8EQMVWbJ-RpUNqdcIkFV0rx_D9H_YLcxU8B5HhI9ofvY_USgrXBLiZrXJA7Rx8-rU9_A3WjPuY |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaq7QGkCvEmUIqRuKFo1_EjDreqotrSshda1JvlRyJSlWRFkgN_gN-NJ3Z2VUGLxDXxTLz2eDxef_MNQu8csbQqtUxL6xc5k4Kk2hq4Zc9JJiyVwo5oi5VYXrBPl_xyBx1NuTAAq4y-P_j00VvHJ_M4mvN1Xc-_ALOL4N6GGBzLC39u3wV2KjZDu4cnp8vVlnuXioBkLEQKAjF3JsC89FUNTIaEjTSeGbttf9pb686PWhXKXdwej4770vFD9CAGlPgw9PkR2imbx2gv_BuHQ5LRE_Trq9fXfv9p6yb152uIGZsej4CA1ntEO3QY2KunpExcN9gHhrie8O0YAGJ48Mv_A45Mote4HXqvs-ywbhzWfSidBZlYXlfXd7it8LdYlSTqfYoujj-eHy3TWIEhtTxb9CmVi8rmXDtunJOEAmbGaX-ANY5RkVMtTM6dEM6YykiqC2YEW5Q-aGKu0Bmhz9CsaZvyBcKOkYJnhhOd-ya8MELnDu4IhcuodS5BZBp3ZSM9OVTJuFYTDu1KwVwpmCsFYLyMJej9RmYdyDnubE2n6VRT2ql3lMrvHXdK5X-TKru41jtFVJephfrDHhPEN5I3TPqfXzy4YWubn5ZJKYUsSIL2J-NT214IIFICwr0Evd289r4CLoB0U7aDb8P9WoRsbZqg58Fot8o51Fwp2Mv_7PUbdG95_vlMnZ2sTl-h-_AmYB730az_MZSvfezWm4O4Nn8DP99Blw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vancomycin-resistant+Enterococcus+colonization+in+the+intensive+care+unit%3A+clinical+outcomes+and+attributable+costs+of+hospitalization&rft.jtitle=American+journal+of+infection+control&rft.au=Jung%2C+Euihan&rft.au=Byun%2C+Sookjin&rft.au=Lee%2C+Hojin&rft.au=Moon%2C+Sang+Yi&rft.date=2014-10-01&rft.eissn=1527-3296&rft.volume=42&rft.issue=10&rft.spage=1062&rft_id=info:doi/10.1016%2Fj.ajic.2014.06.024&rft_id=info%3Apmid%2F25278394&rft.externalDocID=25278394 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01966553%2FS0196655314X00106%2Fcov150h.gif |